• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心脏手术患者分层中,我们是否需要个性化肾功能评估?

Do We Need to Personalize Renal Function Assessment in the Stratification of Patients Undergoing Cardiac Surgery?

作者信息

Arthur Camila P S, Mejia Omar A V, Osternack Diogo, Nakazone Marcelo Arruda, Goncharov Maxim, Lisboa Luiz A F, Dallan Luís A O, Pomerantzeff Pablo M A, Jatene Fabio B

机构信息

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Hospital de Base de São José do Rio Preto, São José do Rio Preto, SP, Brazil.

出版信息

Arq Bras Cardiol. 2017 Oct;109(4):290-298. doi: 10.5935/abc.20170129. Epub 2017 Sep 4.

DOI:10.5935/abc.20170129
PMID:28876374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5644208/
Abstract

BACKGROUND

Renal dysfunction is an independent predictor of morbidity and mortality in cardiac surgery. For a better assessment of renal function, calculation of creatinine clearance (CC) may be necessary.

OBJECTIVE

To objectively evaluate whether CC is a better risk predictor than serum creatinine (SC) in patients undergoing cardiac surgery.

METHODS

Analysis of 3,285 patients registered in a prospective, consecutive and mandatory manner in the Sao Paulo Registry of Cardiovascular Surgery (REPLICCAR) between November 2013 and January 2015. Values of SC, CC (Cockcroft-Gault) and EuroSCORE II were obtained. Association analysis of SC and CC with morbidity and mortality was performed by calibration and discrimination tests. Independent multivariate models with SC and CC were generated by multiple logistic regression to predict morbidity and mortality following cardiac surgery.

RESULTS

Despite the association between SC and mortality, it did not calibrate properly the risk groups. There was an association between CC and mortality with good calibration of risk groups. In mortality risk prediction, SC was uncalibrated with values > 1.35 mg /dL (p < 0.001). The ROC curve showed that CC is better than SC in predicting both morbidity and mortality risk. In the multivariate model without CC, SC was the only predictor of morbidity, whereas in the model without SC, CC was not only a mortality predictor, but also the only morbidity predictor.

CONCLUSION

Compared with SC, CC is a better parameter of renal function in risk stratification of patients undergoing cardiac surgery.

摘要

背景

肾功能不全是心脏手术发病率和死亡率的独立预测因素。为了更好地评估肾功能,可能需要计算肌酐清除率(CC)。

目的

客观评估在接受心脏手术的患者中,CC是否比血清肌酐(SC)是更好的风险预测指标。

方法

对2013年11月至2015年1月期间以前瞻性、连续性和强制性方式登记在圣保罗心血管外科登记处(REPLICCAR)的3285例患者进行分析。获取SC、CC(Cockcroft-Gault公式)和欧洲心脏手术风险评估系统II(EuroSCORE II)的值。通过校准和区分测试对SC和CC与发病率和死亡率进行关联分析。通过多因素逻辑回归生成包含SC和CC的独立多变量模型,以预测心脏手术后的发病率和死亡率。

结果

尽管SC与死亡率之间存在关联,但它未能正确校准风险组。CC与死亡率之间存在关联,且风险组校准良好。在死亡率风险预测中,SC值>1.35mg/dL时未校准(p<0.001)。ROC曲线显示,CC在预测发病率和死亡率风险方面优于SC。在没有CC的多变量模型中,SC是发病率的唯一预测指标,而在没有SC的模型中,CC不仅是死亡率的预测指标,也是唯一的发病率预测指标。

结论

与SC相比,CC是心脏手术患者风险分层中更好的肾功能参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/ada05a6493da/abc-109-04-0290-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/0070907aebd3/abc-109-04-0290-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/a33576d7ae45/abc-109-04-0290-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/f3ea80c1b9ce/abc-109-04-0290-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/ada05a6493da/abc-109-04-0290-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/0070907aebd3/abc-109-04-0290-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/a33576d7ae45/abc-109-04-0290-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/f3ea80c1b9ce/abc-109-04-0290-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/5644208/ada05a6493da/abc-109-04-0290-g04.jpg

相似文献

1
Do We Need to Personalize Renal Function Assessment in the Stratification of Patients Undergoing Cardiac Surgery?在心脏手术患者分层中,我们是否需要个性化肾功能评估?
Arq Bras Cardiol. 2017 Oct;109(4):290-298. doi: 10.5935/abc.20170129. Epub 2017 Sep 4.
2
Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery.肌酐清除率与血清肌酐作为心脏手术风险因素的比较
BMC Surg. 2003 Jun 17;3:4. doi: 10.1186/1471-2482-3-4.
3
Impact of the definition of renal dysfunction on EuroSCORE performance.肾功能不全定义对欧洲心脏手术风险评估系统(EuroSCORE)性能的影响。
J Cardiovasc Surg (Torino). 2009 Oct;50(5):703-9.
4
Serum creatinine values underestimate surgical risk.血清肌酐值会低估手术风险。
Rev Port Cardiol. 2009 Mar;28(3):269-78.
5
Impact of preoperative serum creatinine on short- and long-term mortality after cardiac surgery: a cohort study.术前血清肌酐对心脏手术后短期和长期死亡率的影响:一项队列研究。
Br J Anaesth. 2015 Jan;114(1):53-62. doi: 10.1093/bja/aeu316. Epub 2014 Sep 19.
6
Risk stratification for in-hospital mortality after cardiac surgery: external validation of EuroSCORE II in a prospective regional registry.心脏手术后院内死亡的风险分层:在一个前瞻性区域登记处对欧洲心脏手术风险评估系统II(EuroSCORE II)进行外部验证
Eur J Cardiothorac Surg. 2014 Nov;46(5):840-8. doi: 10.1093/ejcts/ezt657. Epub 2014 Jan 30.
7
An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery: estimated creatinine clearance or plasma creatinine level as measures of renal function.心脏手术中术前肾功能不全与预后的相关性分析:以估算的肌酐清除率或血浆肌酐水平作为肾功能指标
Chest. 2003 Nov;124(5):1852-62. doi: 10.1378/chest.124.5.1852.
8
Validation of age, creatinine and ejection fraction (ACEF) and Cockcroft-Gault ACEF scores in elective cardiac surgery.择期心脏手术中年龄、肌酐和射血分数(ACEF)及Cockcroft-Gault ACEF评分的验证
Medicina (B Aires). 2017;77(4):297-303.
9
The application of European system for cardiac operative risk evaluation II (EuroSCORE II) and Society of Thoracic Surgeons (STS) risk-score for risk stratification in Indian patients undergoing cardiac surgery.欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)风险评分在印度心脏手术患者风险分层中的应用。
Ann Card Anaesth. 2013 Jul-Sep;16(3):163-6. doi: 10.4103/0971-9784.114234.
10
Use of EuroSCORE as a predictor of morbidity after cardiac surgery.
Rev Bras Cir Cardiovasc. 2014 Jan-Mar;29(1):9-15. doi: 10.5935/1678-9741.20140005.

引用本文的文献

1
Preoperative Creatinine Clearance and Mortality of Elective Cardiac Surgery in Hospitalization: A Secondary Analysis.住院择期心脏手术的术前肌酐清除率与死亡率:一项二次分析
Front Cardiovasc Med. 2022 Jan 27;8:712229. doi: 10.3389/fcvm.2021.712229. eCollection 2021.
2
Systematic review of the use of big data to improve surgery in low- and middle-income countries.大数据在中低收入国家改善外科手术中的应用的系统评价。
Br J Surg. 2019 Jan;106(2):e62-e72. doi: 10.1002/bjs.11052.

本文引用的文献

1
Cardiac surgery costs according to the preoperative risk in the Brazilian public health system.巴西公共卫生系统中根据术前风险计算的心脏手术费用。
Arq Bras Cardiol. 2015 Aug;105(2):130-8. doi: 10.5935/abc.20150068. Epub 2015 Jun 23.
2
Risk factors for mortality of patients undergoing coronary artery bypass graft surgery.冠状动脉搭桥手术患者死亡的危险因素。
Rev Bras Cir Cardiovasc. 2014 Oct-Dec;29(4):513-20. doi: 10.5935/1678-9741.20140073.
3
Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery.
接受心脏手术且基线血清肌酐升高的患者中,基于KDIGO(改善全球肾脏病预后组织)标准的急性肾损伤。
Rev Bras Cir Cardiovasc. 2014 Jul-Sep;29(3):299-307. doi: 10.5935/1678-9741.20140049.
4
EuroSCORE II and the importance of a local model, InsCor and the future SP-SCORE.欧洲心脏手术风险评估系统II(EuroSCORE II)与本地模型的重要性、InsCor以及未来的SP评分系统(SP-SCORE)
Rev Bras Cir Cardiovasc. 2014 Jan-Mar;29(1):1-8. doi: 10.5935/1678-9741.20140004.
5
Outcomes of cardiac surgery in chronic kidney disease.慢性肾脏病患者心脏手术的预后
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2167-73. doi: 10.1016/j.jtcvs.2013.12.064. Epub 2014 Jan 15.
6
Heart surgery programs innovation using surgical risk stratification at the São Paulo State Public Healthcare System: SP-SCORE-SUS study.
Rev Bras Cir Cardiovasc. 2013 Jun;28(2):263-9. doi: 10.5935/1678-9741.20130037.
7
InsCor: a simple and accurate method for risk assessment in heart surgery.InsCor:一种用于心脏手术风险评估的简单而准确的方法。
Arq Bras Cardiol. 2013 Mar;100(3):246-54. doi: 10.5935/abc.20130043.
8
Design flaws in EuroSCORE II.
Eur J Cardiothorac Surg. 2013 Apr;43(4):871. doi: 10.1093/ejcts/ezs562. Epub 2012 Oct 25.
9
Effect of preoperative renal function on long-term survival after cardiac surgery.术前肾功能对心脏手术后长期生存的影响。
J Thorac Cardiovasc Surg. 2013 Jul;146(1):90-5. doi: 10.1016/j.jtcvs.2012.06.037. Epub 2012 Jul 25.
10
Coronary artery bypass grafting in acute myocardial infarction: analysis of predictors of in-hospital mortality.
Rev Bras Cir Cardiovasc. 2012 Jan-Mar;27(1):66-74. doi: 10.5935/1678-9741.20120011.